摘要
原发性肝细胞肝癌(HCC)合并胆管癌栓临床少见,增强CT或磁共振成像检查可行临床诊断,手术是其主要治疗手段。笔者报道1例HCC合并胆管癌栓术后复发病人采用免疫联合靶向治疗的临床经验,其研究结果显示:肝内病灶缩小,效果良好。
Hepatocellular carcinoma(HCC)with bile duct tumor thrombus(BDTT)is rare and enhanced CT or MRI can be used for its diagnosis.Surgical procedure is the main treatment for HCC with BDTT.The authors introduce the experiences of recurrent patient with HCC and BDTT who was treated with targeted therapy plus immunotherapy,in order to provide reference for its clinical diagnosis and treatment.
作者
周闯
叶健文
宋盛平
刘文韬
于龙
薛建锋
赵龙栓
翟文龙
Zhou Chuang;Ye Jianwen;Song Shengping;Liu Wentao;Yu Long;Xue Jianfeng;Zhao Longshuan;Zhai Wenlong(Department of Hepatobiliary Pancreatic Surgery,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China)
出处
《中华消化外科杂志》
CAS
CSCD
北大核心
2021年第S02期10-14,共5页
Chinese Journal of Digestive Surgery
基金
河南省科技厅攻关计划资助项目(132300410004)
关键词
肝肿瘤
胆管癌栓
肿瘤复发
靶向治疗
免疫治疗
联合治疗
预后
Liver neoplasms
Bile duct tumor thrombus
Tumor recurrence
Targeted therapy
Immunotherapy
Combination therapy
Prognosis
